头孢哌酮联合舒巴坦治疗急诊重症感染的临床疗效研究
Clinical efficacy of cefoperazone and Shubatan in the treatment of severe acute infection
周垂杨 1夏蕾蕾 1高仁贤 1陈大庆2
作者信息
- 1. 温州医科大学温州市第三临床学院 温州市人民医院 急诊科,浙江 温州 325000
- 2. 温州医科大学附属第二医院 育英儿童医院 急诊科,浙江 温州 325027
- 折叠
摘要
目的 分析头孢哌酮联合舒巴坦治疗急诊重症感染的临床疗效.方法 选取我院100例急诊重症感染患者为研究对象,随机分为对照组和实验组,每组各50例.对照组进行常规治疗,实验组在此基础上给予头孢哌酮联合舒巴坦治疗.密切关注实验组与对照组患者的相关生命体征变化,比较分析2组患者相关临床指标.结果 经过对应的治疗后,实验组细菌除菌率为90.00%,显著高于对照组的除菌率60.00%(P<0.05).实验组治疗有效率为90.00%,显著高于对照组的74.00%(P<0.05).2组患者均未出现明显的不良反应.治疗后,实验组患者生活质量总评分为(75.2±11.2)分,对照组患者生活质量总评分为(64.2±9.3)分,具有统计学意义(P<0.05).结论头孢哌酮联合舒巴坦治疗急诊重症感染临床疗效较为理想,能够显著改善患者临床症状,提高生活质量.
Abstract
Objective To investigate and analyze the clinical efficacy of cefoperazone and Shubatan in the treatment of severe infection in emergency department. Methods 100 cases of severe infection were randomly divided into control group and experimental group, with 50 patients in each group. The control group received routine treatment, and the experimental group was treated with cefoperazone and Shubatan on this basis. Pay close attention to the related vital signs change of the experimental group and the control group, the relevant clinical indicators of the two groups of patients were compared and analyzed. Results After the corresponding treatment, the bacteria removal rate of the experimental group was 90.00%, significantly higher thant 60.00 % of the control group (P<0.05). The effective rate of the experimental group was 90.00%, which was significantly higher than that of the control group (74.00%), which was statistically significant (P<0.05). There were no obvious adverse reactions in the two groups. After treatment, the total score of quality of life in the experimental group was (75.2±11.2) points, and the total score of QOL in the control group was (64.2±9.3) points, which was statistically significant (P<0.05). Conclusion The clinical efficacy of cefoperazone and Shubatan in the treatment of emergency severe infection is satisfactory. It can significantly improve the clinical symptoms and improve the quality of life in patients with severe acute respiratory infection.
关键词
头孢哌酮/舒巴坦/急诊重症感染/临床疗效Key words
cefoperazone/Shubatan/emergency severe infection/clinical efficacy引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据